• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

高强度聚焦超声微创消融治疗毒性甲状腺结节。

Minimally invasive ablation of a toxic thyroid nodule by high-intensity focused ultrasound.

机构信息

ENT and Maxillo Surgery Unit, Paris, France.

出版信息

AJNR Am J Neuroradiol. 2010 Nov;31(10):1967-8. doi: 10.3174/ajnr.A1979. Epub 2010 Jan 14.

DOI:10.3174/ajnr.A1979
PMID:20075098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7964043/
Abstract

HIFU is used in the treatment of cancer (prostate, breast) and uterine fibroma but not yet in TNs. This case report describes the first successful ablation of a toxic TN with HIFU. TSH and radioiodine scan normalization were achieved without complications and maintained for 18 months. HIFU treatment is a minimally invasive technique that may be an effective safe alternative to radioiodine or surgery in patients with toxic TNs.

摘要

高强度聚焦超声（HIFU）用于治疗癌症（前列腺、乳腺）和子宫肌瘤，但尚未用于毒性甲状腺结节（TNs）。本病例报告描述了首例成功应用 HIFU 消融治疗毒性 TN。治疗后患者 TSH 和放射性碘扫描恢复正常，且未发生任何并发症，随访 18 个月仍维持该状态。HIFU 治疗是一种微创技术，对于毒性 TN 患者，它可能是放射性碘或手术治疗的有效替代方法，且安全可行。

相似文献

1
Minimally invasive ablation of a toxic thyroid nodule by high-intensity focused ultrasound.高强度聚焦超声微创消融治疗毒性甲状腺结节。
AJNR Am J Neuroradiol. 2010 Nov;31(10):1967-8. doi: 10.3174/ajnr.A1979. Epub 2010 Jan 14.
2
High-intensity focused ultrasound ablation of thyroid nodules: first human feasibility study.高强度聚焦超声消融甲状腺结节：首例人体可行性研究。
Thyroid. 2011 Sep;21(9):965-73. doi: 10.1089/thy.2011.0141. Epub 2011 Aug 11.
3
High-intensity focused ultrasound (HIFU) therapy for benign thyroid nodules: a 3-year retrospective multicenter follow-up study.高强度聚焦超声（HIFU）治疗良性甲状腺结节：一项 3 年回顾性多中心随访研究。
Int J Hyperthermia. 2020;37(1):1301-1309. doi: 10.1080/02656736.2020.1846795.
4
Significance of hyperechoic marks observed during high-intensity focused ultrasound (HIFU) ablation of benign thyroid nodules.高强度聚焦超声（HIFU）消融良性甲状腺结节时观察到的高回声标记的意义。
Eur Radiol. 2018 Jun;28(6):2675-2681. doi: 10.1007/s00330-017-5207-z. Epub 2018 Jan 8.
5
Single-session high intensity focussed ablation (HIFU) versus open cervical hemithyroidectomy for benign thyroid nodule: analysis on early efficacy, safety and voice quality.单次高强度聚焦超声消融术与开放性甲状腺半切除术治疗良性甲状腺结节：早期疗效、安全性和嗓音质量分析。
Int J Hyperthermia. 2017 Dec;33(8):868-874. doi: 10.1080/02656736.2017.1305127. Epub 2017 Mar 24.
6
High intensity focused ultrasound (HIFU) ablation of benign thyroid nodule is safe and efficacious in patients who continue taking an anti-coagulation or anti-platelet agent in the treatment period.高强度聚焦超声（HIFU）消融治疗期间继续服用抗凝或抗血小板药物的良性甲状腺结节患者是安全有效的。
Int J Hyperthermia. 2019;36(1):186-190. doi: 10.1080/02656736.2018.1548034. Epub 2018 Dec 16.
7
Benign Solid Thyroid Nodules: US-guided High-Intensity Focused Ultrasound Ablation-Initial Clinical Outcomes.良性实性甲状腺结节：超声引导下高强度聚焦超声消融-初步临床结果。
Radiology. 2015 Aug;276(2):597-605. doi: 10.1148/radiol.15141492. Epub 2015 Mar 13.
8
High-intensity focused ultrasound for benign thyroid nodules: Systemic review and meta-analysis.高强度聚焦超声治疗良性甲状腺结节：系统评价与荟萃分析。
Am J Otolaryngol. 2023 Nov-Dec;44(6):103999. doi: 10.1016/j.amjoto.2023.103999. Epub 2023 Jul 11.
9
Sequential high intensity focused ultrasound (HIFU) ablation in the treatment of benign multinodular goitre: an observational retrospective study.序贯高强度聚焦超声（HIFU）消融治疗良性多结节性甲状腺肿：一项观察性回顾性研究。
Eur Radiol. 2018 Aug;28(8):3237-3244. doi: 10.1007/s00330-018-5333-2. Epub 2018 Mar 19.
10
High-intensity focused ultrasound (HIFU) therapy for benign thyroid nodules without anesthesia or sedation.高强度聚焦超声（HIFU）治疗无需麻醉或镇静的良性甲状腺结节。
Endocrine. 2018 Aug;61(2):210-215. doi: 10.1007/s12020-018-1560-1. Epub 2018 Feb 16.

引用本文的文献

1
Efficacy of HIFU for the treatment of benign thyroid nodules: a systematic review and meta-analysis.高强度聚焦超声治疗良性甲状腺结节的疗效：系统评价和荟萃分析。
Eur Radiol. 2024 Apr;34(4):2310-2322. doi: 10.1007/s00330-023-10253-7. Epub 2023 Oct 4.
2
Phenotypic alterations in liver cancer cells induced by mechanochemical disruption.机械化学破坏诱导肝癌细胞表型改变。
Sci Rep. 2019 Dec 20;9(1):19538. doi: 10.1038/s41598-019-55920-2.
3
High-intensity focused ultrasound (HIFU) therapy for benign thyroid nodules without anesthesia or sedation.高强度聚焦超声（HIFU）治疗无需麻醉或镇静的良性甲状腺结节。
Endocrine. 2018 Aug;61(2):210-215. doi: 10.1007/s12020-018-1560-1. Epub 2018 Feb 16.
4
Bortezomib sensitizes thyroid cancer to BRAF inhibitor and .硼替佐米使甲状腺癌对 BRAF 抑制剂敏感。
Endocr Relat Cancer. 2018 Jan;25(1):99-109. doi: 10.1530/ERC-17-0182.
5
Treatment of benign thyroid nodules by high intensity focused ultrasound (HIFU) at different acoustic powers: a study on in-silico phantom.不同声强高强度聚焦超声（HIFU）治疗良性甲状腺结节：仿真体研究。
Endocrine. 2018 Mar;59(3):506-509. doi: 10.1007/s12020-017-1350-1. Epub 2017 Jun 21.
6
High intensity focused ultrasound (HIFU) ablation of benign thyroid nodules - a systematic review.高强度聚焦超声（HIFU）消融治疗良性甲状腺结节——一项系统综述
J Ther Ultrasound. 2017 May 17;5:11. doi: 10.1186/s40349-017-0091-1. eCollection 2017.
7
Image-guided thermal ablation of benign thyroid nodules.影像引导下良性甲状腺结节的热消融术。
J Ultrasound. 2016 Oct 21;20(1):11-22. doi: 10.1007/s40477-016-0221-6. eCollection 2017 Mar.
8
Volume reduction of benign thyroid nodules 3 months after a single treatment with high-intensity focused ultrasound (HIFU).高强度聚焦超声（HIFU）单次治疗3个月后良性甲状腺结节的体积缩小
J Ther Ultrasound. 2015 Mar 4;3:4. doi: 10.1186/s40349-015-0024-9. eCollection 2015.
9
Early assessment of high-intensity focused ultrasound treatment of benign thyroid nodules by scintigraphic means.通过闪烁显像手段对良性甲状腺结节高强度聚焦超声治疗进行早期评估。
J Ther Ultrasound. 2014 Sep 30;2:18. doi: 10.1186/2050-5736-2-18. eCollection 2014.
10
Image-guided percutaneous ablation therapies for local recurrences of thyroid tumors.图像引导经皮消融治疗甲状腺肿瘤局部复发。
J Endocrinol Invest. 2013 Jan;36(1):61-70. doi: 10.1007/BF03346744.

本文引用的文献

1
Percutaneous laser ablation of an autonomous thyroid nodule: effects on nodule size and histopathology of the nodule 2 years after the procedure.经皮激光消融自主性甲状腺结节：术后2年对结节大小及组织病理学的影响
Thyroid. 2008 Jul;18(7):803-5. doi: 10.1089/thy.2007.0316.
2
Radiofrequency ablation for an autonomously functioning thyroid nodule.自主功能性甲状腺结节的射频消融术。
Thyroid. 2008 Jun;18(6):675-6. doi: 10.1089/thy.2007.0274.
3
Percutaneous ethanol injection of hyperfunctioning thyroid nodules: long-term follow-up in 125 patients.经皮乙醇注射治疗功能亢进性甲状腺结节：125例患者的长期随访
AJR Am J Roentgenol. 2008 Mar;190(3):800-8. doi: 10.2214/AJR.07.2668.
4
Transrectal high-intensity focused ultrasound ablation of prostate cancer: effective treatment requiring accurate imaging.经直肠高强度聚焦超声消融治疗前列腺癌：有效的治疗需要精确的成像。
Eur J Radiol. 2007 Sep;63(3):317-27. doi: 10.1016/j.ejrad.2007.06.026. Epub 2007 Aug 6.
5
Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors.高强度聚焦超声治疗复发性和转移性腹部肿瘤患者的并发症
World J Gastroenterol. 2007 May 21;13(19):2747-51. doi: 10.3748/wjg.v13.i19.2747.
6
Effects of percutaneous laser ablation treatment in benign solitary thyroid nodules on nodule volume, thyroglobulin and anti-thyroglobulin levels, and cytopathology of nodule in 1 yr follow-up.经皮激光消融治疗良性孤立性甲状腺结节对结节体积、甲状腺球蛋白及抗甲状腺球蛋白水平的影响以及1年随访中结节的细胞病理学变化
J Endocrinol Invest. 2006 Nov;29(10):876-84. doi: 10.1007/BF03349190.
7
Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules: one versus three treatments.超声引导下间质激光光凝治疗良性孤立性实性冷甲状腺结节：单次治疗与三次治疗的比较
Thyroid. 2006 Aug;16(8):763-8. doi: 10.1089/thy.2006.16.763.
8
Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound.高强度聚焦超声体外诱导肾组织消融
BJU Int. 2006 Apr;97(4):779-85. doi: 10.1111/j.1464-410X.2006.06037.x.
9
Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer.
Breast Cancer Res Treat. 2005 Jul;92(1):51-60. doi: 10.1007/s10549-004-5778-7.
10
Subclinical hyperthyroidism: clinical features and treatment options.亚临床甲状腺功能亢进症：临床特征与治疗选择
Eur J Endocrinol. 2005 Jan;152(1):1-9. doi: 10.1530/eje.1.01809.